Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice

Journal of Neuroimmunology

Volumn 227, Issue 1-2, 2010, Pages 10-17

  Peron, Jean Pierre S ^a   Yang, Kayong ^b   Chen, Mei Ling ^b   Brandao, Wesley Nogueira ^a   Basso, Alexandre S ^c,e   Commodaro, Alessandra G ^a   Weiner, Howard L ^b   Rizzo, Luiz V ^a,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Albert Einstein Jewish Teaching and Research Institute (IIEP)   (Brazil)

^e NONE   (Brazil)

Author keywords

CNS inflammation; EAE; Oral tolerance; Th17

Indexed keywords

ALLERGEN; GLYCOPROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 17; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); NERVE PROTEIN; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; COMPARATIVE STUDY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HELPER CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE DEPLETION; MALE; MOLECULAR GENETICS; MOUSE; ORAL DRUG ADMINISTRATION; PATHOLOGY; PROCEDURES; SECRETION (PROCESS);

ADMINISTRATION, ORAL; ALLERGENS; AMINO ACID SEQUENCE; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLYCOPROTEINS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKIN-17; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 77956647977     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.06.002     Document Type: Article

References (50)

1. Awasthi A., Carrier Y., Peron J.P.S., Bettelli E., Kamanaka M., Flavell R.A., Kuchroo V.K., Oukka M., Weiner H.L. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 2007, 8(12):1380-1389.
2. + Th17 cells in relapsing EAE. Nat. Immunol. 2007, 8:172-180.
3. Benson J.M., Whitacre C.C. The role of clonal deletion and anergy in oral tolerance. Res. Immunol. 1997, 148(8-9):533-541.
4. Betelli E., Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal development pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 2006, (441):235-238.
5. + DCs induces Foxp3 regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007, 8(204):1757-1764.
6. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Wiekowski S., Lira S., Gormank S.A., Kasteleink R.A., Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
7. Das Sarma J., Ciric B., Marek R., Sadhukhan S., Caruso M.L., Shafagh J., Fitzgerald D.C., Shindler K.S., Rostami A. Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis. J. Neuroinfllammation 2009, 6(14):1-12.
8. Ehirchiou D., Xioing Y., Xu G., Chen W., Shi Y., Zhang L. CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation. J. Exp. Med. 2007, 204(7):1519-1524.
9. Faria A.M.C., Weiner H.L. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 1999, (73):153-264.
10. Fischer F.R., Santambrogio L., Luo Y., Berman M.A., Hancock W.W., Dorf M.E. Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression. J. Neuroimmunol. 2000, 110(1-2):195-208.
11. Fitzgerald D.C., Ciric B., Touil T., Harle H., Grammatikopolou J., Das Sarma J., Gran B., Zhang G., Rostami A. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 2007, 179:3268-3275.
12. Goverman J., Perchellet A., Huseby E.S. The role of CD8(+) T cells in multiple sclerosis and its animal models. Curr. Drug Targets Inflamm. Allergy 2005, 4:239-245.
13. Ivanov I., Mackenzie B.S., Zhou B., Tadokoro C.E., Leppeley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
14. Iwakura Y., Ishigame H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 2006, 116(5):1218-1222.
15. Jäger A., Dardalhon V., Sobel R.A., Bettelli E., Kuchroo V.K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 2009, 183(11):7169-7177.
16. Kawanokuchi J., Shimizu K., Nitta A., Yamada K., Mizuno T., Takeuchi H., Suzumura A. Production and functions of IL-17 in microglia. J. Neuroimmunol. 2008, 194:54-61.
17. Keller A.C., Mucida D., Gomes E., Faquim-Mauro E., Faria A.M.C., Rodriguez D., Russo M. Hierarchical suppression of asthma-like responses by mucosal tolerance. J. Allergy Clin. Immunol. 2006, 117(02):283-290.
18. Kleinsheck M., Owyang A.M., Joyce-Shakikh B., Langrish C.L., Cchen Y., Gorman D.M., Blumshein W.M., McClanhan T., Brambacher F., Hurst S.D., Kastelein R.A., Cua D.J. IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 2007, 204(1):161-170.
19. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177(1):566-573.
20. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., Bäckström B.T., Sobel R.A., Wucherpfennig K.W., Strom T.B., Oukka M., Kuchroo V.K. Myelin specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 2007, 13:423-431.
21. Korn T., Bettelli E., Gao Wenda, Awasthi A., Jager A., Strom T.B., Oukka M., Kuchroo V.K. IL-21 initiates an alternative pathway to induce proinflammatory Th17 cells. Nature 2007, 448:484-487.
22. Kreimborg K., Etzensperger R., Dumoutier L., Haak L., Rebollo A., Buch T., Heppner F.L., Renauld J.C., Becher B. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 2007, 279:8098-8104.
23. Kroenke M.A., Segal B.M. Th17 and Th1 responses directed against the immunizing epitope, as opposed to secondary epitopes, dominate the autoimmune repertoire during relapses of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 2007, 85:1685-1693.
24. + T lymphocytes. J. Immunol. 1989, 142:748-752.
25. Lin H.W., Levinson S.W. Context dependent IL-6 potentiation of IFN-γ-induced IL-12 secretion and CD40 expression in murine microglia. J. Neurochem. 2009, 111(3):808-818.
26. Locksley R.M. Nine lives: plasticity among T helper cell subsets. J. Exp. Med. 2009, 3;206(8):1643-1646.
27. Matusevicius D., Kivisäkk P., He B., Kostulas N., Ozenci V., Fredrikson S., Link H. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 1999, 5:101-104.
28. Miller A., Lider O., Roberts A.B., Sporn M.B., Weiner H.L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vivo and in vitro immune responses by the release of TGF-beta following antigen specific triggering. Proc. Natl. Acad. Sci. USA 1992, 89:421-425.
29. + T cells in animal model of collagen-induced arthritis by oral administration of type II collagen. Arthritis Res. Ther. 2004, 6:213-219.
30. Mucida Daniel, Park Y., Kim G., Turovskaya O., Scott L., Kronenberg M., Cheroute H. Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317:256-260.
31. Murphy A.C., Lalo S.J., Lynch M.A., Mills K.H.G. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav. Immun. 2010, 24(4):641-651.
32. Neumann H. Molecular mechanisms of axonal damage in inflammatory central nervous system diseases. Curr. Opin. Neurol. 2003, 16(3):267-273.
33. Peck A., Mellins E.D. Plasticity of T-cell phenotype and function: the T helper type 17 example 2009.
34. Peron J.P.S., Ligeiro de Oliveira A.P., Rizzo L.V. It takes guts for tolerance: the phenomenon of oral tolerance and the regulation of autoimmune response. Autoimmun. Rev. 2009, 9(1):1-4. Sep.
35. Rebenko-Moll N.M., Liu L., Cardona A., Ransohoff R.M. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr. Opin. Immunol. 2006, 18:683-689.
36. Rizzo L.V., Miler-Rivero N., Chan Chi Chao, Wiggert B., Nussenblatt R.B., Caspi R.R. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J. Clin. Invest. 1994, 94(4):1668-1672.
37. Rizzo L.V., Miler-Rivero N., Choi R., Wiggert B., Chan C.C., Morse I., Nussenblatt R.B., Caspi R.R. IL-4 and IL-10 are both required for the induction of oral tolerance. J. Immunol. 1999, 16:2613-2622.
38. Rodriguez M. Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis. Brain Pathol. 2007, 17:219-229.
39. Samoilova E.B., Horton J.L., Zhang H., Khoury S.J., Weiner H.L., Chen Y. CTLA-4 is required for the induction of high dose oral tolerance. Int. Immunol. 1998, 26:1756-1761.
40. Santos L.M.B., Sababgh A., Londono A., Weiner H.L. Oral tolerance to myelin basic protein induces regulatory TGF-beta secreting T cells in PPs of SJL mice. Cell Immunol. 1994, 157:439-447.
41. Song C., Luo L., Lei Z., Li B., Liang Z., Liu G., Li D., Zhang G., Huang B., Feng Z.H. IL-17-producing alvolar macrophages mediate allergic ling inflammation related to asthma. J. Immunol. 2008, 181:6117-6124.
42. Suh E.D.V., Chan C.C., Gery I., Nussenblatt R.B. Splenectomy abrogates the induction of oral tolerance in experimental autoimmune uveoretinitis. Curr. Eye Res. 1993, 12:833-838.
43. Torseth J.W., Gregerson D.S. Oral tolerance in experimental autoimmune uveoretinitis: feeding after disease induction is less protective than prefeeding. Clin. Immunol. Immunopathol. 1998, 88(3):297-304.
44. Weiner H.L. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 2001, 3:947-954.
45. Weiner H.L. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J. Neurol. 2008, 55(1):3-11.
46. Weiner H.L., Mackin G.A., Matsui M., Orav E.J., Khoury S.J., Dawson D.M., Hafler D.A. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993, 259(5099):1321-1324.
47. Vieira P., O' Garra A. Regula'ten' the gut. Nat. Immunol. 2007, 8(9):905-907.
48. Yang K., Vega J., Hadzipasic M., Peron J.P.S., Zhu B., Carrier Y., Masli S., Rizzo L.V., Weiner H.L. Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis. J. Autoimmun. 2009, 32(2):94-103.
49. Zhang X., Izikson L., Liu L., Weiner H.L. Activation of CD25CD4 regulatory T cells by oral antigen administration. J. Immunol. 2001, 167:4245-4253.
50. Zhou L., Ivanov I., Spolski R., Sherendoz K., Egawa T., Levy D.E., Leonard W.J., Littmann D.R. IL-6 programs Th17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007, 8(9):1-8.